Development of CRISPR-CAS9 based RNA drugs against Eimeria tenella infection.

Abstract

Parasitic diseases are major trouble in many parts of the world. We consider that if a chemical can break a DNA barcode sequence, it might be used to develop a species-specific anti-parasitic agent. To examine this hypothesis, we constructed sgRNAs that target both the control (5.8S rDNA) and a DNA barcode (ITS) sequence in Eimeria tenella. In vitro experiment showed that Cas9 mRNA combined with sgRNAs could reduce the sporulation percentage of oocysts and the survival rate of sporulated oocysts and sporozoites. Quantitative real-time PCR showed that the DNAs of parasites exposed to Cas9 mRNA and sgRNAs were significantly affected, regardless of whether they were exposed to a combination of two sgRNAs or just a single sgRNA. The DNA sequencing also indicated that the experimental group exposed to two sgRNAs mixed with Cas9-induced deletion of large parts and a single sgRNA mixed with Cas9-induced mutation at sgRNA targeted fragments. In vivo trial, the effect of sgRNA and Cas9 RNA on the pathogenicity of E. tenella in chicken showed less lesion score and oocysts score (P < 0.05) in experimental groups than control groups. The results and concepts presented in this research can lead to discovering novel nucleic acid therapeutic drugs for Eimeriasis and other parasitic infections, which provide insights into the development of species-specific anti-parasitic agents.

• Authors: Muhammad Mohsin, Yige Li, Xin Zhang, Yilei Wang, Zhijian Huang, Guangwen Yin, Ziping Zhang
• Journal: Genomics (Genomics) Vol. 113 Issue 6 Pg. 4126-4135 (11 2021) ISSN: 1089-8646 [Electronic] United States
• PMID: 34740777 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2021. Published by Elsevier Inc.

Chemical References

• RNA, Messenger
• RNA

Topics

• Animals
• CRISPR-Cas Systems
• Chickens (genetics)
• Eimeria tenella (genetics)
• RNA
• RNA, Messenger (genetics)